United States Arteriovenous Fistula Market to grow CAGR of 5.9% By 2031

The Global Arteriovenous Fistula Market is forecasted to reach at a CAGR of 5.9% during the forecast period (2024-2031).

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/arteriovenous-fistula-market?kb

Latest M&A

✅ Medtronic PLC has continued its strategic acquisitions in vascular access, including the acquisition of Avenu Medical, which develops minimally invasive endovascular AVF creation systems like the Ellipsys Access Vascular system.​

✅ Consolidation in the AVF device market is moderate but ongoing, focused on expanding portfolios of surgical and endovascular devices for dialysis access management.

Key Players:

Pervasis Therapeutics, Inc., Proteon Therapeutics, Inc., Medtronic, Cook Medical, Fresenius Medical Care AG & Co. KGaA, Poly Medicure Limited, Becton Dickinson and Company, Braun Melsungen Ag, Teleflex Incorporated

Growth Forecast Projection:

The Global Arteriovenous Fistula Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Arteriovenous Fistula Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=arteriovenous-fistula-market?kb

Key Segmentation:

By Type: (Radial Cephalic fistula, Brachial Cephalic, Brachial Basilic Transposition)

By Treatment Methods: (Endovascular embolization, Microsurgery, Stereotactic radiosurgery)

Latest Drugs and Product Launches

✅ The FDA designated Laminate Medical's VasQTM External Vascular Support device as a Breakthrough Technology for use in AVF creation. VasQ provides external support to optimize flow and improve fistula maturation rates.​

✅ Various drug-eluting balloon (DEB) technologies such as IN.PACT AV Access have shown improvements in AVF patency, reducing restenosis and reintervention rates in pivotal clinical trials both in the USA and Japan.​

✅ A range of vascular access maintenance devices, including advanced monitoring and flow regulation catheters, have recently launched focusing on improving long-term AVF functionality and patient outcomes.

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Arteriovenous Fistula producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Arteriovenous Fistula revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/arteriovenous-fistula-market?kb

Latest Investments

✅ The US AVF devices market is estimated at approximately $1 billion in 2025 and expected to grow steadily driven by increasing ESRD prevalence requiring dialysis access procedures.​

✅ Japan's AVF devices market generated USD 12.1 million in revenue in 2023 and is forecasted to grow at a CAGR of 8.9%, supported by aging populations and rising CKD cases.​

✅ Investment flows primarily target innovation in minimally invasive AVF creation, drug-coated devices, durability improvement technologies, and AI-assisted vascular access planning.​

Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/arteriovenous-fistula-market?kb

Latest Clinical Trials

✅ Clinical trials in the USA include large post-market studies evaluating VasQ safety and efficacy and drug-coated balloons (DCB) for AVF stenosis prevention and treatment.​

✅ Japan featured in subgroup analyses of the IN.PACT AV Access trial showing significant benefits in target lesion primary patency (TLPP) with drug-coated balloon use in AVF interventions.​

✅ Trials are ongoing of new AVF creation approaches including robotic-assisted vascular surgery and hemodynamic monitoring improving surgical outcomes for dialysis patients.​

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Latest Project Hubs

USA has major vascular access innovation hubs in North Carolina, California, and New York with concentrated R&D and clinical trial activity aligned with national dialysis centers and academic institutions.​

Japan's AVF market is growing through government-backed clinical research at university hospitals and collaborations with medical device companies introducing novel endovascular and drug-eluting technologies

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.